Allan Riting Liu 刘日廷

Allan Riting Liu 刘日廷

Dr. Allan Riting Liu is currently the vice president/senior advisor at Wanbang Biopharmaceutical Group (a subsidiary of Fosun Pharma)for new drug/business development. After graduating from Sun Yat-sen Medical University in 1989, he worked as a sales manager at Xian-Janssen (a J&J). In 1993, he worked as a visiting scholar at New York Medical College. Then he did Ph.D. studies in biochemistry at University of Texas (UT)/M.D. Anderson Cancer Center. After his post-doctoral research at University of Delaware, he worked as a scientist at Eli Lilly’s headquarter for developing osteoporosis and cancer drugs. He also attained an MBA at Purdue University receiving the best scholarship offer. In 2006 after he came back to China, he worked as the director of business development at Fosun Pharma.

Dr. Liu is an internationally well-known professional and among the most outstanding experts in China on pharmaceutical licensing and new drug development. He led to complete about 10 international deals of licensing/technology transfers including the licensing deals for glargine and rh insulin from India, a co-development deal for a FDA phase III potential blockbuster for stroke from Israel. He also developed many new drug proposals for in-house R&D and led the preclinical research, clinical trials and new drug registration for the in-licensed development products. At a doctoral research at UT’s department of integrative biology (chaired by the Nobel Prize winner Dr. Ferid Murad), he became the first scientist in the world to discover that psychosine can mobilize intracellular calcium. In 2003, he received an honor/award as Guidant Scholar offered by Guidant Foundation (U.S.). In 2008, he received an honor as One-Million-Yuan-Subsidized Top Talent offered by Jiangsu Provincial Government of China.

Upcoming Events
Biologics Manufacturing India 2019 13 – 14 February 2019, Hyderabad, India

5th Annual Biologics Manufacturing India 2019 will be the most focused and senior platform in India. Focusing on topics ranging from biomanufacturing to global market expansion, the stage is set for gathering new partnerships, new ideas and new knowledge

.. Read More

 

9th Annual Vaccine World Summit 2019 13 – 14 February 2019, Hyderabad, India

The 9th Annual Vaccine World Summit 2019 is the most sought-after vaccine industrial gathering for emerging market manufacturers. Led by overwhelming demand from the industry, we are bringing the 9th annual

back to Hyderabad, India.

.. Read More

 

Biologics Manufacturing Asia 2019 26 – 28 February 2019, Singapore

In 2019, 400+ biomanufacturing stakeholders from BIG Pharma, Biopharma, Contract Manufacturing Organisations, Academic & Research Institutes, Regulatory Authorities across Singapore, South Korea, Taiwan, Japan, Australia, India, Indonesia, Malaysia,  and China  will convene on the best manufacturing practices in order to have access to faster, cheaper and better biologic drugs!

.. Read More

Biologistics World Asia 2019 26 – 28 February 2019, Singapore

Biologistics World Asia is  THE  ONLY  event in the Asia-Pacific region that focuses on logistics and supply chain of biopharmaceuticals! The event will bring  150+  high-profile attendees together to discuss,  debate and brainstorm on the most pertinent issues affecting the biopharmaceutical logistics network.

.. Read More

 

Biologics World Nordic 2019 5 – 7 March 2019, Stockholm, Sweden

Biologistics World Asia is  THE  ONLY  event in the Asia-Pacific region that focuses on logistics and supply chain of biopharmaceuticals! The event will bring  150+  high-profile attendees together to discuss,  debate and brainstorm on the most pertinent issues affecting the biopharmaceutical logistics network.

.. Read More